NAPSIN A

 Napsin A is an immunohistochemical (IHC) stain used primarily to identify lung adenocarcinomas and distinguish them from other types of lung cancer and metastases. Napsin A is an aspartic proteinase involved in surfactant protein B processing and is highly expressed in type II pneumocytes.

This test is typically used when a pathologist is examining lung tissue samples and needs to determine the type of lung cancer present. It is especially useful in confirming a diagnosis of primary lung adenocarcinoma and differentiating it from squamous cell carcinoma or metastases from extrapulmonary tumors.

The test is carried out on a paraffin-embedded tissue sample using immunohistochemistry. A Napsin A-specific antibody is applied to the tissue, and if the protein is present, it will stain the tumor cells. The pattern and intensity of staining help determine the diagnosis.

A positive Napsin A result supports a diagnosis of lung adenocarcinoma. It is often used in conjunction with other markers, such as TTF-1, to confirm the diagnosis. The absence of Napsin A may suggest a different histological subtype or a non-pulmonary origin of the tumor.

While Napsin A is most commonly associated with lung adenocarcinomas, it may also be expressed in some renal cell carcinomas. However, its expression in other cancers is typically low, making it a relatively specific marker for lung adenocarcinoma in the appropriate clinical context.